Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease

This study aimed to explore the therapeutic effect of Prunus cerasifera Ehrh. Polyphenol (PCP) on high-fat diet-induced metabolic associated fatty liver disease (MAFLD) and its mechanism. Fifty 6-week-old male C57BL/6 mice were randomly divided into a normal group, a model group, a low-dose PCP grou...

Full description

Saved in:
Bibliographic Details
Main Authors: Zaifu ZHOU, Yuxia WANG, Daohong CHEN, Hongbo REN, Quansong LIN
Format: Article
Language:zho
Published: The editorial department of Science and Technology of Food Industry 2025-08-01
Series:Shipin gongye ke-ji
Subjects:
Online Access:http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2025020026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849736729572933632
author Zaifu ZHOU
Yuxia WANG
Daohong CHEN
Hongbo REN
Quansong LIN
author_facet Zaifu ZHOU
Yuxia WANG
Daohong CHEN
Hongbo REN
Quansong LIN
author_sort Zaifu ZHOU
collection DOAJ
description This study aimed to explore the therapeutic effect of Prunus cerasifera Ehrh. Polyphenol (PCP) on high-fat diet-induced metabolic associated fatty liver disease (MAFLD) and its mechanism. Fifty 6-week-old male C57BL/6 mice were randomly divided into a normal group, a model group, a low-dose PCP group (PCP-L, 250 mg/kg), and a high-dose PCP group (PCP-H, 500 mg/kg). A MAFLD model was established using a high-fat diet, and the intervention lasted for 12 weeks. The effects on mice's plasma biochemical indicators, liver tissue biochemical indicators, and liver tissue pathological morphology were observed. The effects of PCP on the liver transcriptome and serum bile acid metabolic profile of mice was also analyzed. The results showed that compared with the model (Mod) group, the levels of AST and ALT in the serum of PCP-L and PCP-H mice were significantly reduced (P<0.01 or P<0.05), and the levels of TC, TG, LDL-C, and FFA in the plasma were significantly decreased (P<0.01 or P<0.05), while the level of HDL-C was notably increased (P<0.01 or P<0.05). In liver tissue, PCP significantly reduced the content of TG and TC (P<0.01 or P<0.05), decreased the levels of pro-inflammatory factors IL-6, IL-1β, and TNF-α (P<0.01 or P<0.05), and increased the levels of liver SOD and GSH (P<0.01 or P<0.05), while reducing the level of MDA (P<0.01 or P<0.05). Histopathological examination of the liver showed that PCP could improve the pathological state of the liver. Transcriptomic results indicated that biological processes such as inflammatory response, lipid metabolism, oxidative stress response, and cell proliferation were significantly upregulated after PCP treatment, with key genes related to lipid metabolism and bile acid synthesis being notably upregulated. Bile acid metabolomic results showed significant changes in the concentration of bile acids such as hyodeoxycholic acid, ursodeoxycholic acid, taurochenodeoxycholic acid, glycocholic acid, and glycoursodeoxycholic acid after PCP treatment. In summary, PCP has a significant therapeutic effect on MAFLD through the regulation of the transcriptome and bile acid metabolism, providing a scientific basis for its potential as a natural product for the treatment of MAFLD.
format Article
id doaj-art-2dd2c834232543c2a06375a1c28c4e3b
institution DOAJ
issn 1002-0306
language zho
publishDate 2025-08-01
publisher The editorial department of Science and Technology of Food Industry
record_format Article
series Shipin gongye ke-ji
spelling doaj-art-2dd2c834232543c2a06375a1c28c4e3b2025-08-20T03:07:11ZzhoThe editorial department of Science and Technology of Food IndustryShipin gongye ke-ji1002-03062025-08-01461644946010.13386/j.issn1002-0306.20250200262025020026-16Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver DiseaseZaifu ZHOU0Yuxia WANG1Daohong CHEN2Hongbo REN3Quansong LIN4Chongqing Chemical Industry Vocational College, Chongqing 401220, ChinaChongqing Medical and Pharmaceutical College, Chongqing 401331, ChinaChongqing Kerui Pharmaceutical (Group) Co., Ltd., Chongqing 400060, ChinaChongqing Kerui Pharmaceutical (Group) Co., Ltd., Chongqing 400060, ChinaChongqing Kerui Pharmaceutical (Group) Co., Ltd., Chongqing 400060, ChinaThis study aimed to explore the therapeutic effect of Prunus cerasifera Ehrh. Polyphenol (PCP) on high-fat diet-induced metabolic associated fatty liver disease (MAFLD) and its mechanism. Fifty 6-week-old male C57BL/6 mice were randomly divided into a normal group, a model group, a low-dose PCP group (PCP-L, 250 mg/kg), and a high-dose PCP group (PCP-H, 500 mg/kg). A MAFLD model was established using a high-fat diet, and the intervention lasted for 12 weeks. The effects on mice's plasma biochemical indicators, liver tissue biochemical indicators, and liver tissue pathological morphology were observed. The effects of PCP on the liver transcriptome and serum bile acid metabolic profile of mice was also analyzed. The results showed that compared with the model (Mod) group, the levels of AST and ALT in the serum of PCP-L and PCP-H mice were significantly reduced (P<0.01 or P<0.05), and the levels of TC, TG, LDL-C, and FFA in the plasma were significantly decreased (P<0.01 or P<0.05), while the level of HDL-C was notably increased (P<0.01 or P<0.05). In liver tissue, PCP significantly reduced the content of TG and TC (P<0.01 or P<0.05), decreased the levels of pro-inflammatory factors IL-6, IL-1β, and TNF-α (P<0.01 or P<0.05), and increased the levels of liver SOD and GSH (P<0.01 or P<0.05), while reducing the level of MDA (P<0.01 or P<0.05). Histopathological examination of the liver showed that PCP could improve the pathological state of the liver. Transcriptomic results indicated that biological processes such as inflammatory response, lipid metabolism, oxidative stress response, and cell proliferation were significantly upregulated after PCP treatment, with key genes related to lipid metabolism and bile acid synthesis being notably upregulated. Bile acid metabolomic results showed significant changes in the concentration of bile acids such as hyodeoxycholic acid, ursodeoxycholic acid, taurochenodeoxycholic acid, glycocholic acid, and glycoursodeoxycholic acid after PCP treatment. In summary, PCP has a significant therapeutic effect on MAFLD through the regulation of the transcriptome and bile acid metabolism, providing a scientific basis for its potential as a natural product for the treatment of MAFLD.http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2025020026prunus cerasifera ehrh. polyphenolmetabolic associated fatty liver diseasetranscriptomicsbile acid metabolomicslipid metabolism
spellingShingle Zaifu ZHOU
Yuxia WANG
Daohong CHEN
Hongbo REN
Quansong LIN
Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
Shipin gongye ke-ji
prunus cerasifera ehrh. polyphenol
metabolic associated fatty liver disease
transcriptomics
bile acid metabolomics
lipid metabolism
title Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
title_full Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
title_fullStr Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
title_full_unstemmed Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
title_short Transcriptomic and Metabolomic Exploration of the Therapeutic Effects of Prunus cerasifera Ehrh. Polyphenol on Metabolic-associated Fatty Liver Disease
title_sort transcriptomic and metabolomic exploration of the therapeutic effects of prunus cerasifera ehrh polyphenol on metabolic associated fatty liver disease
topic prunus cerasifera ehrh. polyphenol
metabolic associated fatty liver disease
transcriptomics
bile acid metabolomics
lipid metabolism
url http://www.spgykj.com/cn/article/doi/10.13386/j.issn1002-0306.2025020026
work_keys_str_mv AT zaifuzhou transcriptomicandmetabolomicexplorationofthetherapeuticeffectsofprunuscerasiferaehrhpolyphenolonmetabolicassociatedfattyliverdisease
AT yuxiawang transcriptomicandmetabolomicexplorationofthetherapeuticeffectsofprunuscerasiferaehrhpolyphenolonmetabolicassociatedfattyliverdisease
AT daohongchen transcriptomicandmetabolomicexplorationofthetherapeuticeffectsofprunuscerasiferaehrhpolyphenolonmetabolicassociatedfattyliverdisease
AT hongboren transcriptomicandmetabolomicexplorationofthetherapeuticeffectsofprunuscerasiferaehrhpolyphenolonmetabolicassociatedfattyliverdisease
AT quansonglin transcriptomicandmetabolomicexplorationofthetherapeuticeffectsofprunuscerasiferaehrhpolyphenolonmetabolicassociatedfattyliverdisease